Search

everythinglearnresearchcommunity

for

Search:↓

Alternative therapies like mushrooms and vinegar extracts can improve health and reduce costs for breast cancer patients.

Tamoxifen caused hair loss in a 52-year-old woman.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

TA-Ado effectively promotes hair growth and reduces hair loss.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Combining pemetrexed with platinum drugs improves treatment outcomes and quality of life for elderly patients with advanced lung adenocarcinoma.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Reporter characteristics affect detection of hair loss from cancer therapy.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

The treatment successfully lowered testosterone levels and reduced symptoms.